Today we announce our financial results for the first quarter of 2021.
We are one of the only pharmaceutical companies in the world focusing exclusively on brain diseases, and we’re set apart by our specialization.
With more than 70 years of neuroscience expertise, Lundbeck has developed and commercialized some of the world's most widely prescribed therapies for brain diseases.
At Lundbeck, we see patients as people and are committed to support the person behind the disease.
Come join us in making a difference to patients worldwide.
Explore the latest financial developments at Lundbeck.
countries where our products are sold
employees supporting our purpose
year Lundbeck was founded